ArticleEndocrine2024

A novel nomogram integrated with preablation stimulated thyroglobulin and thyroglobulin/thyroid-stimulating hormone ratio to predict the therapeutic response of intermediate‑ and high‑risk differentiated thyroid cancer patients: a bi-center retrospective study.

Runze Wen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.